Exelixis, Inc. (EXEL) Social Stream



Exelixis, Inc. (EXEL): $23.29

0.42 (+1.84%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

B

Add EXEL to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#1 of 360

in industry

EXELIXIS INC (EXEL) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering EXELIXIS INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-04 12 $52 $22 $31 $23.74 30.58%
2022-01-06 12 $52 $22 $31.25 $23.74 31.63%
2022-02-18 12 $52 $22 $31.083 $23.74 30.93%
2022-02-22 12 $42 $22 $30.25 $23.74 27.42%
2022-02-23 12 $42 $22 $30.166 $23.74 27.07%
2022-04-12 12 $42 $22 $29.272 $23.74 23.3%
2022-04-13 12 $42 $22 $29.363 $23.74 23.69%
2022-06-05 11 $35 $22 $28.1 $23.74 18.37%
2022-08-01 11 $35 $23 $28.2 $23.74 18.79%
2022-08-23 11 $35 $23 $28.4 $23.74 19.63%
2022-10-14 11 $35 $23 $28.3 $23.74 19.21%
2022-10-26 12 $35 $23 $28.09 $23.74 18.32%
2022-11-01 13 $35 $23 $28.083 $23.74 18.29%
2022-11-02 13 $35 $21 $27.5 $23.74 15.84%
2022-11-03 13 $35 $21 $27.166 $23.74 14.43%
2022-12-09 13 $32 $21 $26.75 $23.74 12.68%
2022-12-11 13 $32 $21 $26.583 $23.74 11.98%
2023-01-10 13 $32 $20 $26.333 $23.74 10.92%
2023-01-11 13 $32 $20 $26 $23.74 9.52%
2023-02-08 13 $32 $20 $25.833 $23.74 8.82%
2023-03-03 14 $32 $20 $25.666 $23.74 8.11%
2023-03-09 14 $32 $20 $25.461 $23.74 7.25%
2023-03-20 13 $32 $20 $24.916 $23.74 4.95%
2023-03-31 13 $32 $20 $25.25 $23.74 6.36%
2023-04-17 11 $32 $20 $25.545 $23.74 7.6%
2023-05-10 13 $32 $20 $25.545 $23.74 7.6%
2023-06-06 13 $32 $20 $25.545 $23.74 7.6%
2023-08-02 13 $32 $20 $25.166 $23.74 6.01%
2023-08-03 14 $32 $20 $25.307 $23.74 6.6%
2023-08-08 15 $32 $18 $24.785 $23.74 4.4%
2023-08-22 15 $32 $18 $24.857 $23.74 4.71%
2023-09-01 16 $32 $18 $25.266 $23.74 6.43%
2023-10-10 18 $32 $18 $26 $23.74 9.52%
2023-11-03 18 $32 $18 $26.117 $23.74 10.01%
2023-11-10 17 $32 $18 $26.312 $23.74 10.83%
2023-12-19 18 $32 $18 $26.764 $23.74 12.74%

The Trend in the Analyst Price Target


EXEL's average price target has moved up $1.29 over the prior 41 weeks.

Over the past 49 weeks, EXEL's average upside potential has been 31.62%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-03 14 32 20 25.666 17.15 49.66%
2023-03-09 14 32 20 25.461 16.67 52.74%
2023-10-26 18 32 18 26.117 20.99 24.43%
2023-11-03 18 32 18 26.117 21.00 24.37%
2023-12-19 17 32 18 26.764 23.84 12.27%

EXEL Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.41 13 1 3 0 0 17

The Trend in the Broker Recommendations


EXEL's average broker recommendation rating improved by 0.23 over the prior 47 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for EXEL as an investment opportunity.

  • In the context of all US stocks, EXELIXIS INC's number of analysts covering the stock is greater than 3419.84% of them.
  • To contextualize these metrics, consider that out of Healthcare stocks, EXELIXIS INC's upside potential (average analyst target price relative to current price) is higher than 1068.43% of them.
  • EXEL has a higher average analyst price target than 1513.71% of Business Services stocks.
  • In the context of stocks in the mid market cap category, EXELIXIS INC's variance in analysts' estimates is lower than -2873.4% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Business Services industry with the ratings most similar to EXELIXIS INC are FTAI, AGTI, and UPWK.

What is the outlook for EXEL? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!